A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)
NCT06191328
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Diabetes
Interventions
DRUG:
Chiglitazar sodium
Sponsor
Yufan Wang